Table 4.
The Questions Related to Access, Distance, and Patient Costs of Treatment (n = 009)
| Total (%) | Female (%) | Male (%) | χ2 (df) or p-value | |
|---|---|---|---|---|
| (1) Are patients' entire treatment complex decongestive therapy free? | ||||
| Yes | 779 (77.21) | 730 (77.49) | 49 (73.13) | 0.68 (1) |
| No | 230 (22.79) | 212 (22.51) | 18 (26.87) | 0.41 |
| (2) If it is not free, could the patient cover the treatment expenses? | ||||
| Yes | 538 (61.14) | 504 (61.61) | 34 (54.84) | 1.11 (1) |
| No | 342 (38.86) | 314 (38.39) | 28 (45.16) | 0.29 |
| (3) Is lymphedema treatment available in a reasonable distance? | ||||
| Yes | 785 (77.95) | 753 (80.02) | 32 (48.48) | 35.69 (1) |
| No | 222 (22.05) | 188 (19.98) | 34 (51.52) | <0.001 |
| (4) Does the distance prevent the patient from accessing a specialist center? | ||||
| Yes | 302 (36.39) | 276 (35.84) | 26 (43.33) | 1.35 (1) |
| No | 528 (63.61) | 494 (64.16) | 34 (56.67) | 0.25 |
| (5) Do patients' lymphedema/wounds prevent discharge from hospital? | ||||
| Yes | 47 (10.26) | 35 (8.47) | 12 (26.67) | 14.58 (1) |
| No | 411 (89.74) | 378 (91.53) | 33 (73.33) | <0.001 |
| (6) Is the patient's lymphedema/wound the main reason for remaining in long-term care? | ||||
| Yes | 79 (17.59) | 63 (15.40) | 16 (40.00) | 15.20 (1) |
| No | 370 (82.41) | 346 (84.60) | 24 (60.00) | <0.001 |
| (7) Is the patient's lymphedema/wound the main reason for remaining in long-term home care? | ||||
| Yes | 50 (11.47) | 40 (10.05) | 10 (26.32) | 9.04 (1) |
| No | 386 (88.53) | 358 (89.95) | 28 (73.68) | 0.003 |